Study Reveals How Tick-Borne Encephalitis Virus Enters Cells
A Cell-Surface Protein Provides Key to Infection BRONX, N.Y., Sept. 24, 2025 /PRNewswire/ — The protein on human cells…
Sleep Aids Market to Hit US$ 118.97 Billion by 2033, Growing at 7.8% CAGR
AUSTIN, Texas and TOKYO, Sept. 19, 2025 /PRNewswire/ — According to DataM Intelligence, the global sleep aids market…
In Vitro Diagnostics (IVD) Quality Control Market worth $2.15 billion by 2030 with 5.5% CAGR
DELRAY BEACH, Fla., Sept. 19, 2025 /PRNewswire/ — The global In Vitro Diagnostics Quality Control Market, valued at…
AAOS Updates Clinical Practice Guideline for the Management of Rotator Cuff Injuries
Updated guideline based on the latest evidence-based recommendations ROSEMONT, Ill., Aug. 28, 2025 /PRNewswire/ — The American Academy…
Barti Raises $12M Series A to Accelerate AI-Powered EHR for Eye Care
SAN FRANCISCO, Aug. 25, 2025 /PRNewswire/ — Barti Software, a leading AI-powered company that provides innovative electronic health records…
Ultima Genomics and Gene by Gene Partner to Expand Global Access to High-Quality, Low-Cost Sequencing on the UG 100™ Platform
Collaboration Extends Global Reach of High-Performance Genomic Sequencing on the UG 100™ Platform FREMONT, Calif. and HOUSTON, Aug.…
Izalontamab Brengitecan (EGFRxHER3 ADC) Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
First Breakthrough Therapy Designation in the U.S. for SystImmune and Bristol Myers Squibb’s Izalontamab brengitecan (Iza-bren) based on data…
Manischewitz and jscreen Launch “Deli is in Your DNA” Tour to Promote Jewish Genetic Health
National campus campaign offers genetic screening, kosher comfort food, and educational outreach just in time for Back-to-School and Tay-Sachs…
Nystrom & Associates Acquires Ellie Mental Health Minnesota
NEW BRIGHTON, Minn., Aug. 4, 2025 /PRNewswire/ — Nystrom & Associates, a leading provider of behavioral health services,…
EVERSANA Announces Development of End-to-End AI-Powered Life Sciences Marketing Agency Built on Google Cloud Technology
CHICAGO, Aug. 4, 2025 /PRNewswire/ — EVERSANA®, a leading provider of commercialization services to the global life sciences industry,…